Streamline Health Solutions Net Income/Loss 2010-2025 | STRM

Streamline Health Solutions net income/loss from 2010 to 2025. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
Streamline Health Solutions Annual Net Income/Loss
(Millions of US $)
2025 $-10
2024 $-19
2023 $-11
2022 $-7
2021 $0
2020 $-3
2019 $-6
2018 $-3
2017 $-5
2016 $-4
2015 $-12
2014 $-12
2013 $-5
2012 $0
2011 $-3
2010 $1
2009 $-1
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.023B $0.018B
Streamline Health Solutions, Inc. is a leading supplier of workflow and document management tools, applications and services that assist strategic business partners and healthcare organizations to improve operational efficiencies through business process optimization. The Company provides integrated tools and technologies for automating document-intensive environments, including document workflow, document management, e-forms, portal connectivity, optical character recognition and interoperability. The Company's workflow-based services offer solutions to inefficient and labor-intensive healthcare business processes throughout the revenue cycle, such as chart coding, abstracting and completion, remote physician order processing, pre-admission registration scanning and signature capture, insurance verification, secondary billing services, explanation of benefits processing and release of information processing.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.605B 59.29
Hims & Hers Health (HIMS) United States $11.194B 116.30
Doximity (DOCS) United States $11.153B 51.63
Tempus AI (TEM) United States $10.574B 0.00
IRhythm Technologies (IRTC) United States $4.258B 0.00
Inspire Medical Systems (INSP) United States $3.817B 59.65
Hinge Health (HNGE) United States $3.642B 0.00
Privia Health (PRVA) United States $2.447B 167.25
Schrodinger (SDGR) United States $1.671B 0.00
Clover Health Investments (CLOV) United States $1.639B 0.00
10x Genomics (TXG) United States $1.600B 0.00
Phreesia (PHR) United States $1.595B 0.00
Enovis (ENOV) United States $1.556B 8.68
Azenta (AZTA) United States $1.507B 70.04
Omnicell (OMCL) United States $1.324B 23.35
Evolent Health (EVH) United States $1.147B 97.70
Claritev (CTEV) United States $0.702B 0.00
Fulgent Genetics (FLGT) United States $0.567B 0.00
Standard BioTools (LAB) United States $0.517B 0.00
Veradigm (MDRX) United States $0.498B 0.00
Butterfly Network (BFLY) United States $0.467B 0.00
Talkspace (TALK) United States $0.435B 130.00
TruBridge (TBRG) United States $0.336B 745.67
Outset Medical (OM) United States $0.336B 0.00
Health Catalyst (HCAT) United States $0.274B 0.00
Nyxoah SA (NYXH) Belgium $0.266B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.229B 0.00
CapsoVision (CV) United States $0.204B 0.00
Zepp Health (ZEPP) Netherlands $0.173B 0.00
KORU Medical Systems (KRMD) United States $0.158B 0.00
Pulmonx (LUNG) United States $0.130B 0.00
American Well (AMWL) United States $0.128B 0.00
MDxHealth SA (MDXH) Belgium $0.114B 0.00
EUDA Health Holdings (EUDA) Singapore $0.112B 0.00
CareCloud (CCLD) United States $0.102B 3.89
Insight Molecular Diagnostics (IMDX) United States $0.081B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.078B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Precipio (PRPO) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Healthcare Triangle (HCTI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00